(Q54265829)

27 May 2018

reason for preferred rank

title

Treatment of advanced untreated Hodgkin's disease with SCAB—an alternative to MOPP (English)

1 reference

10.1002/1097-0142(19810115)47:2<224::AID-CNCR2820470203>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

18 August 2023

Treatment of advanced untreated Hodgkin's disease with SCAB--an alternative to MOPP (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6161689

18 August 2023

1 reference

10.1002/1097-0142(19810115)47:2<224::AID-CNCR2820470203>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

18 August 2023

2

Wiernik PH

1 reference

27 May 2018

author name string

C. H. Diggs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6161689

18 August 2023

J. C. Sutherland

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6161689

18 August 2023

language of work or name

English

0 references

publication date

1 January 1981

1 reference

27 May 2018

15 January 1981

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6161689

full work available at URL

18 August 2023

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

1 reference

10.1002/1097-0142(19810115)47:2<224::AID-CNCR2820470203>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

18 August 2023

1 reference

10.1002/1097-0142(19810115)47:2<224::AID-CNCR2820470203>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

18 August 2023

1 reference

27 May 2018

volume

47

1 reference

27 May 2018

issue

2

1 reference

27 May 2018

page(s)

224-228

1 reference

27 May 2018

Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

cites work

1

1 reference

10.1002/1097-0142(19810115)47:2<224::AID-CNCR2820470203>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

Combination chemotherapy of advanced previously treated Hodgkin's disease with streptozotocin, CCNU, adriamycin and bleomycin

18 August 2023

2

1 reference

10.1002/1097-0142(19810115)47:2<224::AID-CNCR2820470203>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

Adriamycin chemotherapy--efficacy, safety, and pharmacologic basis of an intermittent single high-dosage schedule

18 August 2023

3

1 reference

10.1002/1097-0142(19810115)47:2<224::AID-CNCR2820470203>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease

18 August 2023

4

1 reference

10.1002/1097-0142(19810115)47:2<224::AID-CNCR2820470203>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.

18 August 2023

5

1 reference

10.1002/1097-0142(19810115)47:2<224::AID-CNCR2820470203>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

18 August 2023

7

21

876

Coltman

1973

1 reference

10.1002/1097-0142(19810115)47:2<224::AID-CNCR2820470203>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy

18 August 2023

8

1 reference

10.1002/1097-0142(19810115)47:2<224::AID-CNCR2820470203>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

A New Combination Chemotherapy for Resistant Hodgkin Disease

18 August 2023

9

1 reference

10.1002/1097-0142(19810115)47:2<224::AID-CNCR2820470203>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease

18 August 2023

10

1 reference

10.1002/1097-0142(19810115)47:2<224::AID-CNCR2820470203>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

18 August 2023

12

1 reference

10.1002/1097-0142(19810115)47:2<224::AID-CNCR2820470203>3.0.CO;2-6

https://api.crossref.org/works/10.1002/1097-0142(19810115)47:2%3C224::AID-CNCR2820470203%3E3.0.CO;2-6

18 August 2023

Identifiers

10.1002/1097-0142(19810115)47:2<224::AID-CNCR2820470203>3.0.CO;2-6

1 reference

27 May 2018

1 reference

27 May 2018